Concepedia

Rhyannon Spangler

RS

5

Publications

1.3K

Citations

5

H-Index

2007

Active since

Affiliations

Gilead Sciences (United States)(Current)

Technion – Israel Institute of Technology

Rhyannon Spangler is an author at Gilead Sciences (United States) specializing in medicine, tumor microenvironment, and oxidative stress.

Top concepts

MedicinePathologyImmunologyRedox BiologyTumor BiologyCancer ResearchOxidative StressTumor MicroenvironmentOncologyAngiogenesis

Publications per year

2007–2015

5

Publications

5

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

Vivian Barry-Hamilton, Rhyannon Spangler, Derek Marshall et al. · Nature Medicine · 2010 · 841 citations

Redox Signaling, Allosteric Inhibition, Lysyl Oxidase–like-2 Impedes +7

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

Derek Marshall, Susan K. Lyman, Scott McCauley et al. · PLoS ONE · 2015 · 190 citations · Full text

Inflammation, Tumor Biology, Anti-inflammatory +12

NFATc3 Mediates Chronic Hypoxia-induced Pulmonary Arterial Remodeling with α-Actin Up-regulation

Sergio de Frutos, Rhyannon Spangler, Dominique Alò et al. · Journal of Biological Chemistry · 2007 · 106 citations · Full text

Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours

Shelly Zaffryar‐Eilot, Derek Marshall, Tali Voloshin et al. · Carcinogenesis · 2013 · 89 citations · Full text

Immunology, Pathology, Cancer Biology +20

The Role of LOX and LOXL2 in the Pathogenesis of an Experimental Model of Choroidal Neovascularization

Tine Van Bergen, Rhyannon Spangler, Derek Marshall et al. · Investigative Ophthalmology & Visual Science · 2015 · 34 citations · Full text

Rows per page

1–5 of 5